Brandywine Global Investment Management, LLC Scynexis Inc Transaction History

Brandywine Global Investment Management, LLC

$13.5 Billion
Q1 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$1.77 - $3.87 $40,097 - $87,670	-22,654 Reduced 19.01%	96,546 $180,000
Q4 2021 Feb 11, 2022	SELL	$4.94 - $7.69 $16,796 - $26,146	-3,400 Reduced 2.77%	119,200 $727,000
Q3 2021 Nov 12, 2021	BUY	$5.3 - $7.89 $649,780 - $967,314	122,600 New	122,600 $650,000

Others Institutions Holding SCYX

# of Institutions

Shares Held

15.4M

Call Options Held

Put Options Held

12.9K

Federated Hermes, Inc. Pittsburgh, PA

4.21M
Shares

$8.22 Million
0.01% of portfolio
Kingdon Capital Management, L.L.C. New York, NY

2.24M
Shares

$4.36 Million
0.4% of portfolio
Vanguard Group Inc Valley Forge, PA

1.69M
Shares

$3.29 Million
0.0% of portfolio
Avidity Partners Management LP Dallas, TX

1.45M
Shares

$2.83 Million
0.08% of portfolio
Amh Equity LTD

660K
Shares

$1.29 Million
1.0% of portfolio

View Full List

About SCYNEXIS INC

Ticker SCYX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 32,651,800
Market Cap $63.7M
Description
SCYNEXIS, Inc., a biotechnology company, develops products for the treatment fungal infections in the United States. It offers BREXAFEMME (ibrexafungerp tablets) for the treatment of vulvovaginal candidiasis (VVC). The company is developing its lead product candidate, Ibrexafungerp, as a novel oral and intravenous drug for the treatment of vario...

More about SCYX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brandywine Global Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brandywine Global Investment Management, LLC with notifications on news.

Account